TECHWIRE 30
(CIX: WRAL30)  1,098.87  up arrow+7.37  (0.68 %)  Updated: 03:50 PM EDT, Jul 23 2014
(NQ: Apple)  97.30  up arrow+2.58  (2.72 %)  Updated: 03:51 PM EDT, Jul 23 2014
(NY: QUINTILES)  55.14  up arrow+0.17  (0.31 %)  Updated: 03:50 PM EDT, Jul 23 2014
(OP: BASF SE)  112.68  up arrow+0.91  (0.81 %)  Updated: 03:45 PM EDT, Jul 23 2014
(NQ: BioCryst)  12.06  up arrow+0.4  (3.43 %)  Updated: 03:50 PM EDT, Jul 23 2014
(NQ: BioDelivery)  12.51  down arrow-0.24  (-1.88 %)  Updated: 03:50 PM EDT, Jul 23 2014
(NQ: CEMP)  9.58  up arrow+0.17  (1.81 %)  Updated: 03:50 PM EDT, Jul 23 2014
(NQ: Cisco Systems)  25.67  down arrow-0.28  (-1.08 %)  Updated: 03:51 PM EDT, Jul 23 2014
(NQ: Cree)  48.95  down arrow-1.14  (-2.28 %)  Updated: 03:51 PM EDT, Jul 23 2014
(NQ: DARA)  1.47  up arrow+0.23  (18.55 %)  Updated: 03:50 PM EDT, Jul 23 2014
(NY: EMC CORPORATION)  28.83  up arrow+0.31  (1.09 %)  Updated: 03:51 PM EDT, Jul 23 2014
(NQ: Extreme Networks)  4.93  down arrow-0.22  (-4.27 %)  Updated: 03:51 PM EDT, Jul 23 2014
(NQ: FB)  71.02  up arrow+1.75  (2.53 %)  Updated: 03:51 PM EDT, Jul 23 2014
(NY: GLAXOSMITHKLINE)  50.08  down arrow-3.15  (-5.91 %)  Updated: 03:50 PM EDT, Jul 23 2014
(NQ: GOOG)  596.91  up arrow+2.17  (0.36 %)  Updated: 03:50 PM EDT, Jul 23 2014
(NY: IBM)  193.77  down arrow-0.32  (-0.16 %)  Updated: 03:51 PM EDT, Jul 23 2014
(NY: LH)  105.59  down arrow-0.01  (-0.01 %)  Updated: 03:50 PM EDT, Jul 23 2014
(OP: Lenovo Group)  27.05  down arrow-0.64  (-2.31 %)  Updated: 03:45 PM EDT, Jul 23 2014
(NY: MRK)  58.13  down arrow-0.3  (-0.51 %)  Updated: 03:51 PM EDT, Jul 23 2014
(NQ: Microsoft Corp)  44.87  up arrow+0.04  (0.09 %)  Updated: 03:51 PM EDT, Jul 23 2014
(NQ: NTAP)  37.95  up arrow+0.19  (0.5 %)  Updated: 03:50 PM EDT, Jul 23 2014
(NY: NOVARTIS AG)  89.04  down arrow-0.22  (-0.25 %)  Updated: 03:50 PM EDT, Jul 23 2014
(OP: Novozymes A/S)  50.65  down arrow-0.28  (-0.54 %)  Updated: 03:48 PM EDT, Jul 23 2014
(NY: PFIZER)  30.40  down arrow-0.09  (-0.3 %)  Updated: 03:51 PM EDT, Jul 23 2014
(NQ: Pozen)  8.06  up arrow+0.05  (0.62 %)  Updated: 03:50 PM EDT, Jul 23 2014
(NY: RED HAT)  55.78  up arrow+0.1  (0.18 %)  Updated: 03:50 PM EDT, Jul 23 2014
(NQ: BBRY)  9.82  down arrow-0.1  (-1.01 %)  Updated: 03:50 PM EDT, Jul 23 2014
(NQ: Salix)  132.12  up arrow+0.86  (0.66 %)  Updated: 03:50 PM EDT, Jul 23 2014
(NQ: SQI)  15.00  down arrow-0.3  (-1.97 %)  Updated: 03:50 PM EDT, Jul 23 2014

Posts tagged “Local Firms”

Updated 10:23 a.m. today

GSK sales, earnings slump; shares drop 5%; growth forecast slashed

GSK's HQ in London       Drug giant GlaxoSmithKline, hurt in part by a 20 percent decline in sales in China where the company is under criminal investigation, reports revenues and earnings that missed analysts' expectations on Wednesday. GSK also reduced its growth forecast for 2014 from as much as 8 percent to "basically similar" to 2013 and says it can't estimate what the financial impact could be from the China case.

10:18 a.m. today

CEO on the state of GSK: 'We're making significant progress'

Even with sales and profits declining sharply from a year ago, a cut in a growth forecast for this year and continuing legal issues resulting from a criminal investigation in China, GSK's chief executive officer Andrew Witty puts a positive spin on the state of the company in a video interview.

Top execs discuss GSK earnings, strategy Top execs discuss GSK earnings, strategy

10:47 a.m. yesterday

Comcast earns beat street; TW Cable deal progressing; Verizon earns soar

Comcast pursues Time Warner Cable Comcast on Tuesday beat Street estimates for earnings with high-speed Internet customer growth leading the way; meanwhile, Comcast updates Time Warner acquisition; in other news, Verizon earnings soar.

6:50 a.m. yesterday

Premium Lock Raleigh firm turns to scores of investors to drive female 'Viagra'

Drugs for women Sprout Pharmaceuticals has positioned its drug as the first female equivalent to Viagra. And the privately held firm has turned to scores of investors for financial help in driving the drug toward FDA approval.

11:50 a.m. Monday

ExitEvent news - Ask Scot Wingo: Coming up with your big idea

ExitEvent This is part one of a three-part series on how to turn ideas into companies. This story features Scot Wingo, co-founder and CEO of ChannelAdvisor, and is part the news partnership between WRAL TechWire and ExitEvent.

Updated 9:23 a.m. Monday

RTI wins $3M investment for biofuel research

Under a three-year award from the U.S. Department of Energy, researchers at RTI International are looking at the cost-competitive production of hydrocarbon transportation fuels for less than $3 per gallon.

Biomass and Biofuels Biomass and Biofuels

Updated 9:19 a.m. Monday

Facebook enters Wi-Fi space in Rutherford County Schools

The Broadband Report    The Broadband Report: The Town of Forest City, Rutherford County Schools, PANGAEA Internet, and Facebook are launching a pilot program to bring free Wi-Fi to local students.

7:28 a.m. Monday

Premium Lock Microsoft-Xbox layoffs could impact 'Gears of War' digital series

Nearly the entire staff of the Xbox Entertainment Studios division is being let go as part of Microsoft's huge announced job layoffs. So does this mean now live action video for the "gears of War" franchise Microsoft acquired from Cary-based Epic Games earlier this year? WRAL TechWire Insider John Gaudiosi reports exclusively for Insider subscribers.

Marcus Fenix, the Gears of War star, is back in Gears 3 Marcus Fenix, the Gears of War star, is back in Gears 3

6:51 a.m. Monday

Latest news on wearable medical devices, wireless growing pains, Facebook and muni broadband

Bulldog In the latest Bulldog roundup of life science and technology news: Wear your medicine; Wireless operators' growing pains; Facebook says if you like it, buy it; and Mr. Wheeler, tear down these walls.

6:19 a.m. Monday

Your 48 WRAL TechWire headlines from last week

Week in review Some local websites run one or two tech stories per day. Others a few more but mixed with a variety of business news. At WRAL TechWire, tech and life science make up the menu with nearly 50 stories published over the last five business days. Here's a look back at technology, life science and other related news as reported in WRAL TechWire last week.

July 17

Salix wins FDA approval for drug to treat rare genetic disorder

Salix Raleigh-based Salix Pharmaceuticals has received FDA approval for a drug to treat a rare genetic disorder called hereditary angloedema.

Updated July 17

Startup says aloha to name after Hawaii protests; FDA-Pozen update; new Tantalus exec; Apple $400M ebook settlement; Novartis earnings; Visa's new system

Bulldog In today's Bulldog wrapup of life science and technology news: A L.A. company changes its name after protests in Hawaii; FDA accepts Pozen application; smart grid firm Tantalus in Raleigh names COO; Apple faces $400M ebook settlement; Novartis earnings; and Visa launches new online payment system.

Updated July 17

Premium Lock Is IBM-Apple deal a slap in the face for Lenovo?

If Lenovo has a "parent" in its rise as a global technology powerhouse, it's IBM. After all, Big Blue's sale of its PC division to Lenovo in 2005 took the China-born company international. Now, Lenovo is trying to buy IBM's x86 server business and Google's Motorola Mobility to accelerate growth in servers and smartphones. So what does IBM do as Lenovo grows as a threat to Apple? The Skinny talks with an analyst about IBM's big deal with Apple. Is it a slap in the face to Lenovo? By the way, BlackBerry already is caught up in fallout from the deal.

Apple teams with IBM Apple teams with IBM

Updated July 17

Premium Lock Morrisville-based TyraTech raises $6M, launches head lice product in Europe

TyraTech is rolling out its head lice product in the U.K. and is funding its European expansion with $6 million in new funding. The company, which moved to Morrisville in 2011, says the head lice market is a $150 million a year opportunity.

TyraTech's technology process TyraTech's technology process

Updated July 16

Josh Hardy, treated with experimental Chimerix drug, is going home

Chimerix, the Durham-based drug company working on experimental medicine that could save the life of a seven-year-old Josh Hardy, was granted approval by the U.S. Food and Drug Administration to administer the drug to the boy in March. On Wednesday, his mother said he is doing well and going home.

Josh Hardy Josh Hardy

July 16

Yahoo earnings fall; N.C. Solar Center's new name; Novartis-Google 'Glass' contacts; Cree expands; Sling's new devices

Bulldog In today's Bulldog wrapup of technology and life science news: Yahoo takes a hit; N.C. Solar Center gets a new name; Novartis teams with Google for "Glass" contacts; Cree adds space; Sling's new devices.

July 15

GSK invests up to $25M in new drug manufacturing technology - in Pa., not N.C.

GlaxoSmithKline, which operates a huge drug manufacturing facility in Zebulon, is investing as much as $25 million to license a technology platform from a California firm as part of efforts to develop new drugs. But GSK isn't bringing the platform to N.C., at least initially.

GSK's R&D facility in RTP GSK's R&D facility in RTP

July 14

Finding the next cure? Maybe 1 million hours of supercomputer time will help

Cloud Pharmaceuticals Researchers at Cloud Pharmaceuticals said Monday that they have been granted 1 million hours of use on the IBM Blue Gene/Q Supercomputer for computational drug design and discovery to target orphan diseases including Malaria at Argonne National Laboratory.

July 14

Deadline approaches for CED Tech Venture event

The Council for Entrepreneurial Development's Tech Venture Demo and Showcase deadline to apply is this Thursday.

CED Tech Venture Conference CED Tech Venture Conference

July 14

Raleigh attorney Gary Joyner named RTRP chairman

Gary Joyner The Research Triangle Regional Partnership (RTRP) has elected Gary K. Joyner as its chair for the next two years.

Techwire Inside Partners
The Skinny: A Blog by Rick Smith

OUR INSIDERS

Frank Vinluan
Life science
Dr. Mike Walden
Tech economy
Vivek Wadhwa
Commentary
Scroll